YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
AUSTIN, Texas, June 30, 2026--(BUSINESS WIRE)--Quik!, a forms automation solutions company focused on making paperwork the easiest part of transactions by streamlining the customer experience, has named veteran marketing executive Lori And…
Plantation, Florida, March 23, 2022 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™,Equine Pain-Away™ and Luxury Feet™ in the over-the-counter (OTC) pain management…
Plantation, Florida, March 17, 2022 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™,Equine Pain-Away™ and Luxury Feet™ in the over-the-counter (OTC) pain management…
Plantation, Florida, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in the over-the-counter (OTC) pain management…
CORAL SPRINGS, Fla., May 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced to…
CORAL SPRINGS, Fla., April 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced…
Nutra Pharma is providing comments on the SEC Complaint filed against Nutra Pharma, its CEO and a Consultant to the company. CORAL SPRINGS, Fla., Sept. 28, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC: NPHC), p…
CORAL SPRINGS, Fla., Sept. 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced…
Nutra Pharma is announcing its agreement with an Internet marketing firm for their Over-the-Counter Pain Remedies: Nyloxin® and Pet Pain-Away™ CORAL SPRINGS, Fla., July 17, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Nutra Pharma Corporatio…
Nutra Pharma is announcing the next phase of marketing their Over-the-Counter (OTC) pain reliever for dogs and cats, Pet Pain-Away™ through their direct response partner, DEG Productions CORAL SPRINGS, Fla., July 03, 2018 (GLOBE NEWSWIRE)…
Nutra Pharma is announcing the execution of a Letter of Intent for a $4 Million financing to fund a joint venture for the marketing and distribution of the Company’s Over-the-Counter products. CORAL SPRINGS, Fla., June 28, 2018 (GLOBE NEWS…
Nutra Pharma is announcing the next phase of marketing their Over-the-Counter (OTC) pain reliever for dogs and cats, Pet Pain-Away™ through their direct response partner, DEG Productions. CORAL SPRINGS, Fla., June 06, 2018 (GLOBE NEWSWIRE)…
CORAL SPRINGS, Fla., April 19, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced t…
CORAL SPRINGS, Fla., April 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is…
CORAL SPRINGS, Fla., March 08, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS) and HIV and that also markets the over-the…
CORAL SPRINGS, Fla., Feb. 21, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is…
CORAL SPRINGS, Fla., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS) and HIV and that also markets the over-the-counter (OTC) pain…
CORAL SPRINGS, Fla., Jan. 25, 2018 (GLOBE NEWSWIRE) -- —via OTC PR WIRE-- -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS) and HIV and that also markets the over-…
CORAL SPRINGS, Fla., Jan. 18, 2018 (GLOBE NEWSWIRE) -- -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced…
CORAL SPRINGS, Fla., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing tr…